Navigation Links
Pediatric Researchers Find Possible 'Master Switch' Gene in Juvenile Arthritis
Date:7/1/2008

PHILADELPHIA, July 1 /PRNewswire-USNewswire/ -- Researchers have found that a gene region known to play a role in some varieties of adult rheumatoid arthritis is also present in all types of childhood arthritis. The researchers say the responsible gene may be a "master switch" that helps turn on the debilitating disease.

Researchers at The Children's Hospital of Philadelphia reported on the link between the gene region and juvenile idiopathic arthritis (JIA), formerly called juvenile rheumatoid arthritis. The genetic variant is on chromosome 9 in a region housing two genes, TRAF1 and C5. The TRAF1 gene codes for a protein that regulates tumor necrosis factor, a chemical strongly associated with JIA. However, the researchers say further study is needed to determine whether the TRAF1 gene or the C5 gene is altered in the disease.

The study appears in the July 2008 issue of Arthritis & Rheumatism. Lead authors are Terri H. Finkel, M.D., Ph.D.; Hakon Hakonarson, M.D. Ph.D., director of the Center for Applied Genomics; and Edward M. Behrens, M.D., all of Children's Hospital.

"There are only a few genes that may act as master switches like this to regulate autoimmune diseases," said Finkel, the chief of Rheumatology at Children's Hospital. "This switch we discovered probably has to be an 'ON' gene and when it interacts with other genes and environmental triggers, a child may get juvenile arthritis."

The study compared 67 Caucasian patients being treated for JIA to 1,952 healthy Caucasian control subjects recruited within the hospital's patient network. While the cause of JIA is unknown, results from this study back up past research that shows arthritis arises in a genetically susceptible individual due to environmental factors.

About 300,000 children in the U.S. have JIA, of which about 1,500 children are seen at Children's Hospital. JIA is the inflammation of the lining tissues of a joint and often causes stiffness and pain. Whil
'/>"/>

SOURCE The Children's Hospital of Philadelphia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Childrens Brain Tumor Foundations Tissue Bank Consortium May Solve Dire Problem in Pediatric Cancer Research
2. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
3. Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting
4. New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting
5. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
6. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
7. Curemark Appoints Preeminent Pediatrics Gastroenterologist
8. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
9. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
10. Large Controlled Trial of Widely Used Mood Stabilizers Demonstrates Efficacy in Pediatric Bipolar Disorder
11. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Swissray International, Inc. a lea...ddR ) systems, announced today that its operations...th a long term view towards growing Swissray,s med...ssets and intellectual property, as well as contra...rowth Swissray is now poised to move to the next l...
(Date:11/25/2009)...RNewswire/ -- Cempra Pharmaceuticals Inc. today an...chief executive officer, will present at the Piper...0 a.m. EST, December 1, 2009, at The New York Pala...vide an overview of the company,s two leading anti...-resistant pathogens including MRSA. ,, About ...
(Date:11/25/2009)... JOHANNESBURG, November 25 ,iThemba...very announced today,that they have signed a colla...s, services. , Pyxis,s world class comput...l be coupled with iThemba,s service division to pr... projects identified through Pyxis,international ...
Breaking Medicine Technology:Swissray International Announces New Ownership 2iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Cellular Technology Extends the Boundaries of E healthcare Says Frost 26 Sullivan 50367 1Cellular Technology Extends the Boundaries of E healthcare Says Frost 26 Sullivan 50367 2Cellular Technology Extends the Boundaries of E healthcare Says Frost 26 Sullivan 50367 3Study to see if video games can boost thinking skills in elderly 50364 1Study to see if video games can boost thinking skills in elderly 50364 2Asia Debut for Money Saving Pharma Packaging Machines from Ireland 12839 1Asia Debut for Money Saving Pharma Packaging Machines from Ireland 12839 2Asia Debut for Money Saving Pharma Packaging Machines from Ireland 12839 3
... Bleeding in Patients Treated for Acute Coronary S... One Year, NEW ORLEANS, March 26, 2007 /PRNewswire...ial show that acute coronary syndrome,(ACS) patien...ent,group had similar rates of ischemic clinical o...erapy, confirming previous findings,which showed ...
...al Analysis Shows Statistically Significant Change..., Calif., March 26, 2007 /PRNewswire-FirstCall/ --...tive initial,results from its Phase IIa clinical t...enic patients with acute agitation. The 10 mg,dose...l trial,which was a statistically-significant red...
Other Medicine Technology:Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 2Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 3Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 4Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 5Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 6Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 2Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 4Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 5Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 6
(Date:11/26/2009)...TON, N.J., Nov. 27 The diabetes po...ver the next 25 years and annual medical spending ...p from $113 billion today, according to a study pu... The National Changing Diabetes ® Program (N...analysis by a team from the University of Chicago....
(Date:11/26/2009)...ering drug tetrathiomolybdate (TM) has been shown ...son disease, a disease caused by an overload of co... known. Very little, however, is known about how t...udy led by Northwestern University researchers now...ional structure of TM bound to copper-loaded metal...
(Date:11/26/2009)...rill when on an emotional rollercoaster, study fin...) -- Call it the fear factor meets the jubilant sp...s -- especially those who root for the winning tea...sely contested match and victory was in doubt, pro...ew on that this Thanksgiving weekend as you,re glu...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center,...s , is one of a growing number of physicians who a...sites to connect with individuals who are interest...id obesity. Dr. Kim is utilizing Facebook to share... practice with the community. , ...
(Date:11/26/2009)... Benton Communications announces a highly eff...or retailers struggling to make an economic recove..., 2009 -- Flu fears is the type of challenge that ...oom, according to Dr. David Benton, business growt... growth system – The Rfactor Intensive . ...
Breaking Medicine News(10 mins):Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
... More than 1,500 CME Sessions Viewed at www.Card...une 2009 , Boston, MA (PR...gural online medical conference for physicians and...ation , which includes video webcasts and a facul...
...nt adoption of programs designed to improve health... April 2 CVS Caremark (NYSE: CVS ) today announ...hat a majority of the company,s employer clients s... by simply shifting costs to the member. In fact,...
...AS, Inc. (Nasdaq: AMCS ) a leader in radiology a...ons, today announced the successful completion of ...ICAS Acquisition Corp. for shares of common stock ...wscom.com/cgi-bin/prnh/20060202/AMICASLOGO ) , ...
...Endoscopy, Inc. (OTC Pink Sheets: SNDY) is pleased...endocoupler with an eye piece for the MammoView(TM...will allow the MammoView scope to be used by a maj...could not utilize the standard endocoupler. The n...
...ril 2, 2009 AMERIGROUP Corporation (NYSE: AGP...s for the first quarter ended March 31, 2009, at a... 1, 2009. At 8:30 a.m. Eastern Time on the same d...0-3161 (domestic) or 706-679-7245 (international) ...
... Slow, Hospitals and Treatment Centers Seek Compet...NTA, April 2 For oncology programs struggling to ...s appealing. The pressure to gain efficiencies com...al push to implement electronic medical records (E...
Other Medicine News:Health News:CardioCareLive.com, First Ever Online Cardiometabolic Conference, Revolutionizes Continuing Medical Education for Cardiovascular Healthcare Professionals 2Health News:CVS Caremark Announces Results of Annual Employer Survey Validating Proactive Pharmacy Care Approach 2Health News:CVS Caremark Announces Results of Annual Employer Survey Validating Proactive Pharmacy Care Approach 3Health News:CVS Caremark Announces Results of Annual Employer Survey Validating Proactive Pharmacy Care Approach 4Health News:AMICAS Successfully Completes Tender Offer for Shares of Emageon Inc. 2Health News:Solos Endoscopy, Inc. Develops Specialized Endocoupler for the MammoView(TM) 2Health News:AMERIGROUP Corporation to Discuss First Quarter Earnings on May 1 2Health News:Hospitals Turn to Vendors Like Elekta for Help in Squeezing Most From Existing Technologies 2Health News:Hospitals Turn to Vendors Like Elekta for Help in Squeezing Most From Existing Technologies 3
...ted Aumated Immunoassay Analyzer that fits in any ...16 X 16 X 21 inches and weighs approximately 60 lb...e laboratories, work stations for small hospitals,...a dedicated system for specialty testing. With a t...
...automation and continuous random access capabiliti...ssays for thyroid, anemia, cardiac, reproductive, ...g are currently available, with infectious disease...ltaneously process 60 accessible samples for a thr...
...tic Drug Monitoring Market in 1981 with the introd... uses technology known as FPIA (Fluorescence Polar...ration in a patient. Therapeutic Drugs, used in th... narrow therapeutic range requiring close monitori...
Architect i2000
Medicine Products: